-
Confident Fitzpatrick makes a run at another US Open title
-
Neymar? He is working remotely at the World Cup, jokes Lula
-
England captain Stokes strikes for Durham as Test recall looms
-
Three-time Stanley Cup champion Toews retires
-
Clark wants to win back fans as well as US Open title
-
Japan wary of fired up and wounded Tunisia for World Cup landmark game
-
Clark leads as fellow major winners charge at US Open
-
'Like a fridge': France cave homes offer lucky few respite from heat
-
Ton-up Nicholls turns the screw for New Zealand against England
-
Hormuz ship traffic climbs after war deal: trackers
-
Sun shines on jockey Lee at Royal Ascot
-
Kane hails World Cup 'Wonderwall' singalong as England highlight
-
Sabalenka roars back to make Berlin WTA semis
-
Europe swelters as more heat records set to tumble
-
Narvaez takes Swiss Tour third stage after 100km breakaway
-
'There's no soul': Tony Leung weighs in on AI in filmmaking
-
Europe swelters as temperature records tumble
-
From Versailles to a Swiss mountain: a week of dizzying Iran diplomacy
-
French mountain lodges worry over strained water supply
-
Coach tells S. Korea to move on fast with World Cup knockouts in reach
-
Heatwave hits more than one in two people in France
-
Henry strikes as New Zealand strengthen grip against England
-
Zverev sets up Fritz semi at Halle Open
-
England captain Stokes in action for Durham as Test recall looms
-
Clark stumbles but still leads by two at US Open
-
Moutet fined over x-rated Queen's Club rant
-
Ogura pulls off stunner to top Czech MotoGP practices
-
Outrage in Italy after Trump says Meloni 'begged' for photo op
-
Turkey bars public World Cup screening over university entrance exam
-
From birds to fish, how extreme heat causes wildlife to suffer
-
Ebola spreading 'fast' in DR Congo, warns WHO
-
Trapped on Everest for days, Nepali survivor recounts escape
-
The Sun may not engulf Earth after all, scientists say
-
Clark leads by three as US Open second round begins
-
Russia signals slower rate cuts amid high Ukraine war spending
-
Fritz gets revenge on Shelton to reach Halle semis
-
Henry strikes as New Zealand lead England by 100 runs in 2nd Test
-
Heatwave hits more than half of France's population
-
Online threats, insults fuel S.Africa's anti-foreigner hate
-
Former England keeper Earps agrees to join London City Lionesses
-
Clark completes first round with two-stroke US Open lead
-
Olympic hurdles medallist Bascou suspended for doping
-
Italian FM cancels US visit over reported Trump comments
-
Pegula sinks Keys to reach Berlin Open semis
-
Oil prices, shares steady after US-Iran talks postponed
-
Gaza ceasefire a 'deadly illusion': UNICEF
-
What did we learn from the hantavirus cruise ship scare?
-
S.Africa anti-migrant hate loses team African support at World Cup
-
Arsenal will start Premier League title defence against Coventry
-
European robotics start-ups go up against Chinese heavyweights
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
C.Amaral--PC